Clinical Trials Logo

Filter by:
NCT ID: NCT06005675 Active, not recruiting - Cataracts Clinical Trials

User Acceptability Evaluation of Pseudophakic Patients Previously Implanted With the TECNIS Odyssey IOL

Start date: September 6, 2023
Phase:
Study type: Observational

Prospective collection of data from medical records, multicenter, post-market clinical follow-up study.

NCT ID: NCT06005441 Active, not recruiting - Subcutaneous Fat Clinical Trials

A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.

Start date: November 10, 2023
Phase: Phase 2
Study type: Interventional

This is a randomized, placebo-controlled, Phase 2b study to evaluate the efficacy, safety, and tolerability of CBL-514 injection compared with CBL-A1 and CBL-A2 for reducing subcutaneous fat.

NCT ID: NCT06004479 Active, not recruiting - Pregnancy Related Clinical Trials

Maternal Carotenoids Across Pregnancy Study

MCAPS
Start date: September 14, 2022
Phase:
Study type: Observational

Before infants are born, they depend on their mother to provide the nutrients necessary to grow and develop, such as iron, folic acid, iodine and other vitamins and minerals. Pregnant people also rely on good nutrition to support their own health. In addition to essential nutrients, vitamins, and minerals, there are other natural components found in fruits and vegetables, called phytochemicals, that may support maternal and fetal health during pregnancy. While more is known about the role of phytochemicals in adult health, surprisingly little is known about phytochemical nutrition during pregnancy. This study focuses on a group of phytochemicals, called carotenoids, during pregnancy. The study will determine if and why levels of carotenoids in the body change across the course of pregnancy. Understanding carotenoid nutrition during pregnancy will improve the understanding ofnutrition needs of expectant mothers and their infants. To study these questions, both health pregnant and non-pregnant female adults will report on their dietary intake and participate in body measurements, health surveys, and carotenoid measurements of eyes, skin, and blood at time points corresponding with the first, second, and third trimesters of pregnancy as well as post-partum.

NCT ID: NCT06004388 Active, not recruiting - Migraine Clinical Trials

Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)

Start date: July 21, 2023
Phase: Phase 3
Study type: Interventional

Randomized study of two digital therapeutics for the prevention of episodic migraine in patients currently receiving Calcitonin Gene-Related Peptide (CGRP) Inhibitor Therapy

NCT ID: NCT06003790 Active, not recruiting - Chronic Stroke Clinical Trials

Facilitators and Barriers to the Clinical Implementation of MR-001

RhaPSody
Start date: August 29, 2023
Phase: N/A
Study type: Interventional

This is a single arm, multi-site, prospective hybrid implementation and feasibility trial. The primary purpose of this trial is to gather data on the facilitators and barriers to clinical implementation of MR-001 for patients with chronic stroke who experience walking impairments. Secondarily, the trial will evaluate the feasibility of MR-001 clinically impacting walking capacity, quality of life, mood, and cognition. The goal of this single arm, multi-site, prospective hybrid implementation and feasibility trial is to gather data on the facilitators and barriers to clinical implementation of MR-001 for patient with chronic stroke who experience walking impairments. The main questions it aims to answer are: 1. Enhance understanding of the potential clinical and operational needs and opportunities that may be associated with implementation of MR-001 in various treatment settings. 2. Assess the impact of MR-001 on walking capacity. 3. Assess the impact of MR-001 on quality of life and mood. 4. Assess the impact of MR-001 on cognition. All participants will be prescribed MR-001 and will be asked to walk with it for 30 minutes, 3 times weekly, for 8 weeks.

NCT ID: NCT06003049 Active, not recruiting - COPD Clinical Trials

A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD

Start date: October 1, 2023
Phase: Phase 2
Study type: Interventional

The aim of this clinical trial to determine the safety and effectiveness of treating the COPD symptoms with subcutaneous BOTOX injections in participants with moderate COPD.

NCT ID: NCT06002503 Active, not recruiting - Vaccine Reaction Clinical Trials

Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection

Start date: October 16, 2023
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to evaluate the safety and reactogenicity of a VEE DNA Vaccine candidate delivered by either intramuscular or intradermal jet injection. The main question it aims to answer is: • Is the VEE DNA Vaccine candidate safe Participants will: - Receive the VEE DNA Vaccine candidate by either intramuscular or intradermal jet injection - Provide blood and urine samples - Complete ECGs - Complete physical exams - Complete diaries

NCT ID: NCT06001736 Active, not recruiting - Stroke, Ischemic Clinical Trials

Utility of CC7 Transfer in Stroke Subtypes

Start date: March 13, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the limb functional improvement after contralateral C7 root transfer in stroke patients.

NCT ID: NCT06001398 Active, not recruiting - Clinical trials for Pediatric Feeding Dysfunction, Acute

Parent Acceptance and Commitment Therapy (PACT) for Parents of Children With Pediatric Feeding Disorder

PACT
Start date: June 27, 2023
Phase: N/A
Study type: Interventional

This is a pilot study of randomized clinical trial of Parent Acceptance and Commitment Therapy (PACT) vs. an attention-control condition (placebo) for improving the mental health of parents of children with pediatric feeding disorder. The goal of this clinical trial is to compare two programs in parents of children with pediatric feeding disorders. The main question[s] it aims to answer are: - PACT will result in clinically meaningful reductions in Mental Health(MH) problems among parents of children with Pediatric Feed Disorder (PFD) - Identify factors that impact the feasibility of PACT delivery - Participants will asked to participate in one of two programs focused on parents of children with pediatric feeding disorders. - The participants will also be asked to complete a battery of questionnaires at four timepoints during the study. - The parents will be asked to video record a meal time twice during study. If there is a comparison group: Researchers will compare the PACT group with a control group to see if PACT will result in clinically meaningful change in parent stress and anxiety, and parent use of positive mealtime behaviors.

NCT ID: NCT06000696 Active, not recruiting - COPD Clinical Trials

Healthy at Home Pilot

Start date: September 9, 2022
Phase:
Study type: Observational [Patient Registry]

The objective is to conduct a pilot-feasibility trial of the "Healthy at Home" program, a multimodal intervention aimed at preventing acute care needs among COPD patients. The program will feature a digital platform and virtual pulmonary rehabilitation to facilitate complex care management of UMass Memorial Health Patients